Interferon lambda has been cleared
"ZymoGenetics Inc. (ZGEN: News ) announced that its collaboration with Bristol-Myers Squibb Co. (BMY: News ) for hepatitis C compound PEG-Interferon lambda has been cleared by the United States Federal Trade Commission and Department of Justice clearance under provisions of the Hart-Scott-Rodino Antitrust Improvements Act."
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home